{"name":"Rhythm Pharmaceuticals, Inc.","slug":"rhythm-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE5PSklkcXY5cW45V1Nxbm96bHNTX2FRQ2RXcnlON2ZseHNuUXVjaGNWbVBZVkN1Q0c4SjJyR3IxN25WYUpQOGRzMVJfZzlkUFpfZmc?oc=5","date":"2026-04-05","type":"pipeline","source":"Yahoo Finance UK","summary":"Rhythm Pharmaceuticals, Inc. (RYTM) stock price, news, quote and history - Yahoo Finance UK","headline":"Rhythm Pharmaceuticals, Inc. (RYTM) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxObHVLWVI0UlpvQV8tNkdpdC13QWYweHJ6MGZJeGg5RlZPT2w5VGpNUlB0Xzd2RWFnTHlZdDJRQVR6SFJ2ZHdkRUg1ZlM3bnNJNHZidEpEbUpKMXdXRTQ1SzBIV3hkT3VmaHR1STM0Njl0ZkVoLVQ5dlFsU01WcEFKY1QxRUpTNUhUMVktaUhlRnBLS0dfVVlJTU5sREhKUFAtdERnZUhoR19HUXQtanB3ZnJ1RnRaYXJxeFozYjhET0hLdnJKb21GcnR5Uzk1TnVES0EwY2tOUko?oc=5","date":"2026-04-05","type":"trial","source":"MSN","summary":"Rhythm Pharma down after late-stage trial setback for lead asset in rare obesity disorders - MSN","headline":"Rhythm Pharma down after late-stage trial setback for lead asset in rare obesity disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQV3FCcTdHTmNHSzFXVkVTTE9sbU9OUXBWajB0d2JTc0g4TFZLekNtbHd4SElmcEpaZkJvZ1hXTU1TVURRelV5dW5QX1hnSUNubUstMWo3OFo0S2JqVEdjVUk4a1UyQlhqZXo1YWxhLVFqQlY5X3FBY2lOaW9nbE9WRHVrNXVoS1cybUdkVHVadlJFeXp4aWIxQ1h2YmV4NmtoMC1TYllNZHFyeE1lYTd2XzE3WHBNYmFwSVFXdzlhTUJNQzFkeVNJdkF3Yw?oc=5","date":"2026-04-03","type":"pipeline","source":"Stock Titan","summary":"Rhythm Pharmaceuticals (RYTM) director Kimberly Popovits files initial Form 3 - Stock Titan","headline":"Rhythm Pharmaceuticals (RYTM) director Kimberly Popovits files initial Form 3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxOclJUeEI2cEYwZlA3MFJybVhsNFpFNno0NGt2NjhpbTVvNmhWVGVLQW9iSDRqYmFTeE5TeFJFTEh3NFVyamZ4bXdmYVF3bHAxUFVIeGJQcnZyOXhGM1pTMmUtSkQ3aVNseERCZWtOcFMtZG96WVNIMEFhYURLcUwtNWFEQmdkZGlFTXpVcGNQUjlfLTNCekpZOGNGelZZTTNBYTlaR2VVV0dVbmV2MkpfT2JwN0lUZnFyYms4c3oydk1LMGkwMG51dDlKOGd4YWtUWTFfc2RGZ1ZvbFdkZkJ1eE1na1pFVGtqeHBmcUd3eWV5YjZSVzh5N0kzRWRLbVZkN19oYUE4bVlDMHcwREc0MC1vd1ltM0RzaWtORVlKX25uc2NVX2NPT19n?oc=5","date":"2026-03-20","type":"pipeline","source":"prnewswire.com","summary":"PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide) - prnewswire.com","headline":"PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indicat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxObkxHc3lCUy1CYm9fZFpvdERqVEhFZlY3cDZoWXZfNHd6RU9zTGppczJvUGlYWUVpclg1a3hMS05qVFBoNl9pSW9TeVR0NDJVZUNYOUFJU2luOU1Cemd3cGZDbFpvV0dnQlZHU3Y3TDFTOTdrVG5PZFliZE4xLUJjR3lJdUxvb3VpcGxYNjJlaw?oc=5","date":"2026-03-20","type":"regulatory","source":"seekingalpha.com","summary":"Rhythm Pharma higher after FDA label expansion for lead drug - seekingalpha.com","headline":"Rhythm Pharma higher after FDA label expansion for lead drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQdDhjVDNGYmU1SnNtNURYbEFsTUlFYTM5M0NhT2lXOC1wZEI0Y2xOcW5kUmQ4V05IaHJjMHFlcFJDZ2UwM1cyTldxWVR4V0F4eWRsbnd1RFlhQTdTY3V6NlpleDY5V0J5QUNkcUc3VklDcHNOeUVfODJRWVRfNzRQRElWNnhhRlpYU1ZjWmVyTjhMOWx5M1MtZExsSUR6M21RUFFtU2JuRllKcmV4VEIybGh1SVNxZw?oc=5","date":"2026-03-20","type":"pipeline","source":"Stock Titan","summary":"Rare obesity treatment for hypothalamic injury patients gets one U.S. pharmacy - Stock Titan","headline":"Rare obesity treatment for hypothalamic injury patients gets one U.S. pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNS2Nkc1BNQzVjekZHZGFuR2hXaW9MdTd0RWNkT0pHajBJTjlmZ1RycVV6dkd2Wk9jS0t2NjN5XzAxNWdhQ0Z0ellSSmU2VGNKZUZwMEJOaldOU29iOTZWWFdSMk5FOVZNSTlTQ0dXZ0lOVVVfUU15clJxS2FzMW5fOUJ1d2lyVXYyV1V6TjNMWURmcUhYUktMQ2hDREF2Zmk1cFZiaVRTb09iWVZCY01OVzV1c3BRN2d0Qk8yVDE3SnR1d3RoOUV3?oc=5","date":"2026-03-16","type":"trial","source":"Investing.com","summary":"Rhythm Pharma shares fall as obesity drug trial fails to meet main goal - Investing.com","headline":"Rhythm Pharma shares fall as obesity drug trial fails to meet main goal","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOcm9UWmJQeWRsR1RLYWhyY3k4ZG8zLUNBUURhOXA0YnBiTmxZRXNuX25yODlneVFGZW50clQ5bXdJeFR1NFFBR1RaY28zbEx2Q3c2QWhHN2RsTjVMRHhSc3YwODBBRlFyZk5CYzB6bmNFMHh4X3dFS204RTZpRUQyS1JWdk8zZHA1TXBsa2o1bTVETDRTRzRMajZmLU9IcTZVQTVlLUxoZGREQ3BVX2V1QTZncmJ4T1E?oc=5","date":"2026-03-16","type":"trial","source":"Stock Titan","summary":"Obesity drug trial misses goal, yet some patients cut BMI by 9.7% - Stock Titan","headline":"Obesity drug trial misses goal, yet some patients cut BMI by 9.7%","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxORTlBcEtTRzNMM2NGSF9BbkQ4S0hMXzdtcDdJLU9zSVp6a3VuaVVDY0hHMEs4ZE04WndjOHB4QmhHUUthSk0wNTlvdk9TWHROenppeWY3LVdSaVFSaVluc283U0JFOW1WZThWSHk4MmNRY0RvWjl5T3ZfSHdlcUlCb1FoZGE2V05icDNibGVhVXpfc1BDeEVaRGZXY3FLeXRWZ1dBQ0ttN0N2OGU5M0V2emU3Zm5uTGstOWVGRQ?oc=5","date":"2026-03-16","type":"pipeline","source":"Stock Titan","summary":"Trust for Rhythm Pharmaceuticals (RYTM) director receives 4,199 shares - Stock Titan","headline":"Trust for Rhythm Pharmaceuticals (RYTM) director receives 4,199 shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNWnZBWGxVbldZVWVPMlU5OFNvaHJUTDQwM1ZfMUg1U3R3bmc0d3BXLWVVMklMN1RHRFlEX2VKVGtheF9NYWI4VThEMHh4em11aTc2RXJBaFkwWGgycGhJcGZiSzJUcXFaWVBCa0hRS0tvUXJnTU5WbGhUX1Z6RWRBRVQ3cVUydkJobzFXTUl4SDB6Y0psel95bGtncjJjZDdiZFp1NVY1ZjBKa3hFV3ZNNHhpblQ0RnN5RXdtUw?oc=5","date":"2026-03-06","type":"pipeline","source":"Stock Titan","summary":"Rhythm Pharmaceuticals (NASDAQ: RYTM) CAO exercises options, sells shares - Stock Titan","headline":"Rhythm Pharmaceuticals (NASDAQ: RYTM) CAO exercises options, sells shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5jeUU1WHhuTUtmaTAySG9lOHVmQ00tUnJtdnlFM0x3WVhzZFhoZUZQWnZBVEhscHg0azJua1BZQU5sSGNremNvQ1ctamZNNHNOUjQtS2RtZU9NMkZK?oc=5","date":"2025-12-29","type":"pipeline","source":"Finimize","summary":"Rhythm Pharma’s Rare-Obesity Drug Keeps Growth Rolling - Finimize","headline":"Rhythm Pharma’s Rare-Obesity Drug Keeps Growth Rolling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxONFpMUWxMR1pFeGw5Wk43RlpHeWYxZjBjeVVhQ2xKTFVhQlVYR3E4dFFWVGl4djc1alMzUlRMLWRwdUg2aGdYTGZXdlpUN1JYYkVwVlZ3d0N2UUEwaUtWNmJyeHhsUXpPM25yQm5QQUloS3RrNWtNUXR4YXNPXzJrMXZuVzMwaWdwUG9TUUNrNGw5a3phNmg5WmNGTDdnWXJqRXpraUxB?oc=5","date":"2025-12-11","type":"pipeline","source":"Investor's Business Daily","summary":"Rhythm Pharma Hits Record High On Unexpected Obesity-Tied Win - Investor's Business Daily","headline":"Rhythm Pharma Hits Record High On Unexpected Obesity-Tied Win - Investor's Business Daily","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}